Search

Your search keyword '"de Baere T"' showing total 31 results

Search Constraints

Start Over You searched for: Author "de Baere T" Remove constraint Author: "de Baere T" Journal annals of oncology Remove constraint Journal: annals of oncology
31 results on '"de Baere T"'

Search Results

1. Starting the fight in the tumor: expert recommendations for the development of human intratumoral immunotherapy (HIT-IT)

3. Conversion to resection of liver metastases from colorectal cancer with hepatic artery infusion of combined chemotherapy and systemic cetuximab in multicenter trial OPTILIV

5. 489P Analysis of 3-dimensional volumetric distribution and dispersion of the radioenhancer NBTXR3 in various solid malignancies

9. 993P NBTXR3 radiation enhancing hafnium oxide nanoparticles: RP2D for the treatment of HCC and liver metastases

11. Phase I/II trial of NBTXR3 activated by SBRT in patients with hepatocellular carcinoma or liver metastasis

12. Hafnium oxide nanoparticles activated by SBRT: a new interventional radiation therapy approach for the treatment of unresectable liver cancers

13. Everolimus after transarterial liver therapy of metastases from gastrointestinal neuroendocrine tumors: The FFCD 1104-EVACEL-GTE phase II study

14. Hepatocellular carcinoma and liver metastasis treated by hafnium oxide nanoparticles activated by stereotactic body radiation therapy

15. Molecular screening in advanced cancer patients with head and neck cancers: A retrospective analysis of the MOSCATO-01 trial

16. Precision medicine for patients with rare cancers: An effective strategy within the prospective MOSCATO trial

17. A phase I/II trial of hafnium oxide nanoparticles activated by radiotherapy in hepatocellular carcinoma and liver metastasis

18. Precision medicine for patients with advanced biliary tract cancers: Updated results from the prospective MOSCATO trial

21. Clinical efficacy of HER3 partners' inhibitors in ERBB3 mutated cancer patients

28. Prognostic Factors of Tumour Cellularity in Image-Guided Biopsies: Results from a Prospective Molecular Triage Trial (Moscato)

29. Hepatic Arterial Infusion (HAI) of Oxaliplatin Plus Intravenous (IV) Fluorouracil (FU), Leucovorin (LV) and Cetuximab for First-Line Treatment of Unresectable Colorectal Liver Metastases (CRLM): Final Results of a Multicenter Phase 2 Study (CHOICE)

Catalog

Books, media, physical & digital resources